ArticleThe journal of headache and pain2024

Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany.

Armin Scheffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.